Shock wave therapy is a non-invasive treatment used in wide areas of medical field, such as urology, cardiology, orthopedics, and physical therapy, among others. It is an alternative for orthopedic ...

The FDA has approved the sale of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. The FDA has approved the sale of the Dermapace System, the first shock wave ...

Saudi Arabian Shock Wave Therapy Devices Market · GlobeNewswire Inc. Dublin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Shock Wave Therapy Devices Market Report and Forecast 2025-2034" has ...

With the number of bogus remedies and treatments floating around, claiming to provide relief for various ailments, the FDA really has its work cut out for it. I mean, can you imagine trying to wade ...

People walk into physiotherapy clinics with all kinds of expectations. Some have been managing discomfort for months. Others want to return to a spot they love. Another group may simply ...

Shock wave therapy improves pain and urinary symptoms in men with type IIIB chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

PulseVet, which is backed by Branford Castle, has acquired NeoPulse from Switalis. No financial terms were disclosed. NeoPulse is a provider of shock wave devices. New York, Jan. 28, 2021– Branford ...

Source: Getty Images In a randomized trial, investigators compared low-intensity shock save therapy with a sham procedure in men with vasculogenic erectile dysfunction. Low-intensity shock wave ...

Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. "Diabetes is the leading cause of ...

Dublin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Shock Wave Therapy Devices Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The Saudi Arabia shock ...

(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the Saudi Arabia shock wave therapy devices market include rising demand for non-invasive treatments driven by high nephrolithiasis rates and ...